Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 709, pseudogene (RN7SL709P)

Target
RN7SL709P
Molecular classification
Other (non-coding RNA pseudogene)
01

Overview

RNA, 7SL, cytoplasmic 709, pseudogene (RN7SL709P) is a non-functional genetic element classified as a *pseudogene*. It is a truncated sequence homologous to the 7SL RNA gene, which is an essential noncoding RNA forming the backbone of the signal recognition particle (SRP) complex. While functional 7SL RNA participates in protein synthesis and intracellular trafficking by arresting translation and mediating protein translocation to membranes[1][5], pseudogenes such as RN7SL709P do not generate a functional RNA product and thus have no known biological or disease roles. Pseudogenes can occasionally produce transcripts but are generally considered genetic "dead-ends" without therapeutic or biomarker potential[4][3]. RN7SL709P is a *pseudogene*, not a functional molecule, receptor, or enzyme. It is not considered a therapeutic target. Its inclusion as a "target" is incorrect, unless the intent is to study its genomic context or its rare regulatory effects as a pseudogene. Normally, only functional genes or proteins (receptors, enzymes, transporters, etc.) are designated as therapeutic targets or relevant biomarkers[4][3].

Other names
7SL RNA pseudogeneRN7SL709P
02

Mechanism of action

None (for the pseudogene)

03

Biological functions

None (for the pseudogene itself); functional paralog is involved in SRP complex assembly, protein targeting[1][5]
04

Disease associations

None reported (for this pseudogene); functional paralog involved in cancer proliferation as a noncoding RNA biomarker[5]
05

Safety considerations

None (for the pseudogene)
06

Interacting drugs

None (for the pseudogene)
07

Biomarkers

None established for this pseudogene; functional paralog sometimes used as cancer biomarker[5]

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 709, pseudogene (RN7SL709P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 709, pseudogene (RN7SL709P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call